Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1535期
关键词：
SUBUNIT VACCINE; EFFICACY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [21] Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
    Lecrenier, Nicolas
    Beukelaers, Pierre
    Colindres, Romulo
    Curran, Desmond
    De Kesel, Carine
    De Saegher, Jean-Philippe
    Didierlaurent, Arnaud M.
    Ledent, Edouard Y.
    Mols, Johann F.
    Mrkvan, Tomas
    Normand-Bayle, Marie
    Oostvogels, Lidia
    Da Silva, Fernanda Tavares
    Vassilev, Ventzislav
    Vinals, Carlota
    Brecx, Alain
    EXPERT REVIEW OF VACCINES, 2018, 17 (07) : 619 - 634
  • [22] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Le, Phuc
    Rothberg, Michael B.
    JAMA INTERNAL MEDICINE, 2018, 178 (02) : 248 - 258
  • [23] Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
    Curran, Desmond
    Oostvogels, Lidia
    Heineman, Thomas
    Matthews, Sean
    McElhaney, Janet
    McNeil, Shelly
    Diez-Domingo, Javier
    Lal, Himal
    Andrews, Charles
    Athan, Eugene
    Berglund, Johan
    Campora, Laura
    de Looze, Ferdinandus
    Korhonen, Tiina
    Leung, Edward
    Levin, Myron
    Volpi, Antonio
    Johnson, Robert W.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2019, 74 (08): : 1231 - 1238
  • [24] Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
    Teng, Lida
    Mizukami, Akiko
    Ng, Cheryl
    Giannelos, Nikolaos
    Curran, Desmond
    Sato, Tomohide
    Lee, Christa
    Matsuki, Taizo
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1447 - 1467
  • [25] A critical appraisal of "Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
    Bharucha, Tehmina
    Ming, Damien
    Breuer, Judith
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1789 - 1797
  • [26] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Tavares-Da-Silva, Fernanda
    Mahaux, Olivia
    Van Holle, Lionel
    Haguinet, Francois
    Seifert, Harry
    Stegmann, Jens-Ulrich
    DRUG SAFETY, 2020, 43 (12) : 1223 - 1234
  • [27] Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
    Giannelos, Nikolaos
    Ng, Cheryl
    Curran, Desmond
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [28] Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
    Curran, Desmond
    Patterson, Brandon J.
    Van Oorschot, Desiree
    Buck, Philip O.
    Carrico, Justin
    Hicks, Katherine A.
    Lee, Bruce
    Yawn, Barbara P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 765 - 771
  • [29] Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
    Schwarz, Tino F.
    Aggarwal, Naresh
    Moeckesch, Beate
    Schenkenberger, Isabelle
    Claeys, Carine
    Douha, Martine
    Godeaux, Olivier
    Grupping, Katrijn
    Heineman, Thomas C.
    Fauqued, Marta Lopez
    Oostvogels, Lidia
    Van den Steen, Peter
    Lal, Himal
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11): : 1352 - 1361
  • [30] A Medical Records Review Study Assessing Safety of Zoster Vaccine Recombinant, Adjuvanted in Patients With Rheumatic Disease
    Gupta, Surbhi
    Arasaratnam, Reuben J.
    Solow, E. Blair
    Bajaj, Puneet
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E528 - E531
12345